TRPC1 and hypertrophic cardiomyopathy: Induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients exhibited diastolic dysfunction at the cellular level and increased expression of TRPC1 (Wu et al., 2019).